DOI: 10.1055/s-00000175

Arzneimittelforschung

LinksClose Window

References

Vogel CL, Cobleigh MA, Tripathy D et al.
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

J Clin Oncol 2002;
20: 719-726

Download Bibliographical Data

Access:
Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.